Herpes zoster and postherpetic neuralgia.
Loeser
John D
JD
Department of Neurological Surgery, and Multidisciplinary Pain Center, University of Washington, RI-20, Seattle, WA98195 U.S.A.
D000212:Acyclovir / Q000627:therapeutic use; D000249:Adenosine Monophosphate / Q000627:therapeutic use; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000779:Anesthetics, Local / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D005260:Female; D006562:Herpes Zoster / Q000150:complications* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009407:Nerve Block; D009437:Neuralgia / Q000209:etiology* / Q000628:therapy; D010640:Phenothiazines
D000305:Adrenal Cortex Hormones; D000779:Anesthetics, Local; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D010640:Phenothiazines; D003561:Cytarabine; D000249:Adenosine Monophosphate; D000212:Acyclovir; D004121:Dimethyl Sulfoxide